Investigating Voice as a Biomarker for leucine-rich repeat kinase 2-Associated Parkinson's Disease
Authors:
S. Arora,
N. P. Visanji,
T. A. Mestre,
A. Tsanas,
A. AlDakheel,
B. S. Connolly,
C. Gasca-Salas,
D. S. Kern,
J. Jain,
E. J. Slow,
A. Faust-Socher,
A. E. Lang,
M. A. Little,
C. Marras
Abstract:
We investigate the potential association between leucine-rich repeat kinase 2 (LRRK2) mutations and voice. Sustained phonations ('aaah' sounds) were recorded from 7 individuals with LRRK2-associated Parkinson's disease (PD), 17 participants with idiopathic PD (iPD), 20 non-manifesting LRRK2-mutation carriers, 25 related non-carriers, and 26 controls. In distinguishing LRRK2-associated PD and iPD,…
▽ More
We investigate the potential association between leucine-rich repeat kinase 2 (LRRK2) mutations and voice. Sustained phonations ('aaah' sounds) were recorded from 7 individuals with LRRK2-associated Parkinson's disease (PD), 17 participants with idiopathic PD (iPD), 20 non-manifesting LRRK2-mutation carriers, 25 related non-carriers, and 26 controls. In distinguishing LRRK2-associated PD and iPD, the mean sensitivity was 95.4% (SD 17.8%) and mean specificity was 89.6% (SD 26.5%). Voice features for non-manifesting carriers, related non-carriers, and controls were much less discriminatory. Vocal deficits in LRRK2-associated PD may be different than those in iPD. These preliminary results warrant longitudinal analyses and replication in larger cohorts
△ Less
Submitted 20 October, 2018;
originally announced October 2018.
Vision-Based Assessment of Parkinsonism and Levodopa-Induced Dyskinesia with Deep Learning Pose Estimation
Authors:
Michael H. Li,
Tiago A. Mestre,
Susan H. Fox,
Babak Taati
Abstract:
Objective: To apply deep learning pose estimation algorithms for vision-based assessment of parkinsonism and levodopa-induced dyskinesia (LID). Methods: Nine participants with Parkinson's disease (PD) and LID completed a levodopa infusion protocol, where symptoms were assessed at regular intervals using the Unified Dyskinesia Rating Scale (UDysRS) and Unified Parkinson's Disease Rating Scale (UPDR…
▽ More
Objective: To apply deep learning pose estimation algorithms for vision-based assessment of parkinsonism and levodopa-induced dyskinesia (LID). Methods: Nine participants with Parkinson's disease (PD) and LID completed a levodopa infusion protocol, where symptoms were assessed at regular intervals using the Unified Dyskinesia Rating Scale (UDysRS) and Unified Parkinson's Disease Rating Scale (UPDRS). A state-of-the-art deep learning pose estimation method was used to extract movement trajectories from videos of PD assessments. Features of the movement trajectories were used to detect and estimate the severity of parkinsonism and LID using random forest. Communication and drinking tasks were used to assess LID, while leg agility and toe tap** tasks were used to assess parkinsonism. Feature sets from tasks were also combined to predict total UDysRS and UPDRS Part III scores. Results: For LID, the communication task yielded the best results for dyskinesia (severity estimation: r = 0.661, detection: AUC = 0.930). For parkinsonism, leg agility had better results for severity estimation (r = 0.618), while toe tap** was better for detection (AUC = 0.773). UDysRS and UPDRS Part III scores were predicted with r = 0.741 and 0.530, respectively. Conclusion: This paper presents the first application of deep learning for vision-based assessment of parkinsonism and LID and demonstrates promising performance for the future translation of deep learning to PD clinical practices. Significance: The proposed system provides insight into the potential of computer vision and deep learning for clinical application in PD.
△ Less
Submitted 1 August, 2017; v1 submitted 25 July, 2017;
originally announced July 2017.
